FDA compounding committee sets meeting

NCPA May 6, 2022

FDA announced that the Pharmacy Compounding Advisory Committee will meet on June 8. The committee will discuss the following four bulk drug substances nominated for inclusion on the 503A Bulks List: ammonium tetrathiomolybdate, enclomiphene citrate, ferric subsulfate, and glutathione. NCPA will coordinate presentations on ammonium tetrahiomolybdate and glutathione for the June 8 meeting.